Modelling The Costs and Outcomes Associated With Sequence Of Treatment With And Without Tofacitinib For The Treatment of Moderate to Severe Rheumatoid Arthritis In The Us
May 1, 2015, 00:00
10.1016/j.jval.2015.03.932
https://www.valueinhealthjournal.com/article/S1098-3015(15)00989-4/fulltext
Title :
Modelling The Costs and Outcomes Associated With Sequence Of Treatment With And Without Tofacitinib For The Treatment of Moderate to Severe Rheumatoid Arthritis In The Us
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00989-4&doi=10.1016/j.jval.2015.03.932
First page :
A161
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
383